Hernandez-Valladares, M.; Wangen, R.; Aasebø, E.; Reikvam, H.; Berven, F.S.; Selheim, F.; Bruserud, Ø.
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid. Cancers 2021, 13, 2143.
https://doi.org/10.3390/cancers13092143
AMA Style
Hernandez-Valladares M, Wangen R, Aasebø E, Reikvam H, Berven FS, Selheim F, Bruserud Ø.
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid. Cancers. 2021; 13(9):2143.
https://doi.org/10.3390/cancers13092143
Chicago/Turabian Style
Hernandez-Valladares, Maria, Rebecca Wangen, Elise Aasebø, Håkon Reikvam, Frode S. Berven, Frode Selheim, and Øystein Bruserud.
2021. "Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid" Cancers 13, no. 9: 2143.
https://doi.org/10.3390/cancers13092143
APA Style
Hernandez-Valladares, M., Wangen, R., Aasebø, E., Reikvam, H., Berven, F. S., Selheim, F., & Bruserud, Ø.
(2021). Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid. Cancers, 13(9), 2143.
https://doi.org/10.3390/cancers13092143